Details
Clemens Ortlepp is the Co-Founder and Chief Product Officer (CPO) of BIO Protocol.
Work Experience
Relevance Person
Nate Hindman
Nate Hindman is responsible for Growth at BIO Protocol. Initially, he was a journalist and later became a marketing leader. He has worked with startups and Fortune 100 companies to scale products and platforms from inception to a global level.
Jaeyawat
Jaeyawat is the APAC Ecosystem Developer at BIO Protocol.
Sean Brennan
Sean Brennan is head of AI agency at Bio and previously worked at MakerDAO and Infura.
Tyler Golato
Tyler Golato is a partner at Triplicate and co-founder of Molecule, an open-source protocol for drug development. Previously, he worked at the National Institute of Aging Research (NIH/NIA/IRP) under the guidance of Dr. David M. Wilson III and Dr. Vilhelm Bohr, focusing on repairing endogenous DNA damage, especially in the context of aging. Additionally, Tyler co-founded VitaDAO and bio.xyz. Before working in DeSci, Tyler had an accomplished early career as a biochemist, molecular biologist and biogerontologist.
Paul Kohlhaas
Paul Kohlhaas is an entrepreneur and economist with a passion for open source utility networks. A profound passion for pharmaceutical innovation led him to found Molecule, a networked marketplace that enables the distributed R&D and funding of new chemical intellectual property. His research centers around the use of token engineering and autonomous market design to design novel incentive and legal structures that drive open source collaboration. He previously graduated in economics and politics from the University of St. Gallen, co-founded Linum Labs, a blockchain architecture studio and worked 1.5 years at ConsenSys, uPort, pioneering early real-world implementations in digital identity.
Jose Pinto
Jose Pinto is the Legal Counsel for BIO Protocol.
James Sinka
James Sinka is responsible for Community and R&D at BIO Protocol.
Leonard Boltz
Leonard Boltz is a core contributor at BIO Protocol.
William Fang
William Fang is currently a Strategy Lead at BIO Protocol.Previously he worked at Sora Ventures and Goldman Sachs. He graduated from Tsinghua University.